These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16574201)

  • 1. Prophylaxis in rare coagulation disorders -- factor X deficiency.
    Auerswald G
    Thromb Res; 2006; 118 Suppl 1():S29-31. PubMed ID: 16574201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis in rare coagulation disorders -- factor XIII deficiency.
    Nugent DJ
    Thromb Res; 2006; 118 Suppl 1():S23-8. PubMed ID: 16616323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe factor X deficiency due to a homozygous mutation (Cys364Arg) that disrupts a disulphide bond in the catalytic domain.
    Todd T; Perry DJ; Hayman E; Lawrence K; Gattens M; Baglin T
    Haemophilia; 2006 Nov; 12(6):621-4. PubMed ID: 17083512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor X deficiency.
    Menegatti M; Peyvandi F
    Semin Thromb Hemost; 2009 Jun; 35(4):407-15. PubMed ID: 19598069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital bleeding disorders of the vitamin K-dependent clotting factors.
    Girolami A; Scandellari R; Scapin M; Vettore S
    Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
    Girolami A; Ruzzon E; Tezza F; Scandellari R; Scapin M; Scarparo P
    Haemophilia; 2008 Mar; 14(2):323-8. PubMed ID: 18081833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of prophylaxis and genotype-phenotype correlation in patients with severe Factor X deficiency in Iran.
    Karimi M; Vafafar A; Haghpanah S; Payandeh M; Eshghi P; Hoofar H; Afrasiabi A; Gerdabi J; Ardeshiri R; Menegatti M; Peyvandi F
    Haemophilia; 2012 Mar; 18(2):211-5. PubMed ID: 21854511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency.
    Menegatti M; Karimi M; Garagiola I; Mannucci P; Peyvandi F
    Am J Hematol; 2004 Sep; 77(1):90-1. PubMed ID: 15307115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor X deficiency in North Pakistan.
    Anwar M; Hamdani SN; Ayyub M; Ali W
    J Ayub Med Coll Abbottabad; 2004; 16(3):1-4. PubMed ID: 15631360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice.
    Dewerchin M; Liang Z; Moons L; Carmeliet P; Castellino FJ; Collen D; Rosen ED
    Thromb Haemost; 2000 Feb; 83(2):185-90. PubMed ID: 10739370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of inherited factor X deficiency.
    Brown DL; Kouides PA
    Haemophilia; 2008 Nov; 14(6):1176-82. PubMed ID: 19141158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM; Easley RB; Tobias JD
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor X deficiency and intracranial bleeding: who is at risk?
    Rauch R; Girisch M; Wiegand G; Schroeder W; Hofbeck M; Welisch E; Wulff K
    Haemophilia; 2011 Sep; 17(5):759-63. PubMed ID: 21682820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency undergoing surgery.
    Escobar MA; Auerswald G; Austin S; Huang JN; Norton M; Millar CM
    Haemophilia; 2016 Sep; 22(5):713-20. PubMed ID: 27217097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency.
    Austin SK; Kavakli K; Norton M; Peyvandi F; Shapiro A;
    Haemophilia; 2016 May; 22(3):419-25. PubMed ID: 27197801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous major bleeding in acquired factor X deficiency secondary to AL-amyloidosis.
    Enjeti AK; Walsh M; Seldon M
    Haemophilia; 2005 Sep; 11(5):535-8. PubMed ID: 16128899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
    Payne JH; Maclean RM; Hampton KK; Baxter AJ; Makris M
    Haemophilia; 2007 Jan; 13(1):93-7. PubMed ID: 17212732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of the p.Gly262Asp mutation in congenital Factor X deficiency.
    Epcacan S; Menegatti M; Akbayram S; Cairo A; Peyvandi F; Oner AF
    Eur J Clin Invest; 2015 Oct; 45(10):1087-91. PubMed ID: 26222694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis with prothrombin complex concentrate in four children with severe congenital factor X deficiency.
    Bowles L; Baker K; Khair K; Mathias M; Liesner R
    Haemophilia; 2009 Jan; 15(1):401-3. PubMed ID: 19149864
    [No Abstract]   [Full Text] [Related]  

  • 20. Central nervous system bleeding in patients with rare bleeding disorders.
    Siboni SM; Zanon E; Sottilotta G; Consonni D; Castaman G; Mikovic D; Biondo F; Tagliaferri A; Iorio A; Mannucci PM; Peyvandi F
    Haemophilia; 2012 Jan; 18(1):34-8. PubMed ID: 21539694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.